Old bbara post on Sanofi and Novo issued 500M shares to the U.S. Stock registry in 4Q. What were they for?
bbarra1 • Jan 15, 2014 6:57 PM Flag
Just to recap:
#1. Avis and Marlin posted that both Sanofi and Novo issued 500M shares to the U.S. Stock registry in 4Q 2013; - see the link to the SEC filing posted by Marlin.
#2. Jan 7, 2014, MNKD is awarded a patent for combination Afrezza/Lantus and Afrezza/Novo's product - 20 years exclusive patent - See the thread on U.S. Patent this week.
#3. MNKD authorized shares is 500M.
#4. MNKD started a clinical trials for a new vendor supplier for raw insulin for Afrezza
$5 No word on EU filing
#6 Sanofi partnered with Pfizer to acquire Exubera. Sanofi sold its share to Pfizer for $3.2B after disagreement on how to market the product; Sanofi bought the Exubera plant in Germany from Pfizer.
#7 A stock swap.of 1 MNKD for 1 SNY + 1 NVO = $89; A price good enough for Al, don't you think? And it will cost Sanofi and Novo what? Temporary dilution?
#8 Sanofi owns Europe/Asia market; Novo U.S. Market?